Search Results
Dec 15, 2025, 08:30 ET Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering
including LEU011 for the treatment of solid tumours. In vivo CAR-T cell engineering, which generates CAR-T cells directly within the body, addresses many limitations of conventional CAR-T cell therapies. Enabling in vivo delivery removes the need for extensive and complex ex vivo
More news about: Leucid Bio
Dec 15, 2025, 08:00 ET Immusoft Secures FDA Orphan Drug Designation for ISP-002 in MPS II, a Progressive Lysosomal Storage Disease
caused by a deficiency of the enzyme iduronate-2-sulfatase (IDS), which leads to the progressive accumulation of glycosaminoglycans throughout the body. The disease results in multi-system pathology, including skeletal abnormalities, cardiopulmonary complications, and reduced life expectancy. While enzyme
More news about: Immusoft
Dec 15, 2025, 08:00 ET Rona Therapeutics Advances INHBE siRNA Into Phase 1 Clinical Development
Phase 1 study is a randomized, double-blind, placebo-controlled study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and effect on body weight in adults with overweight and obesity. Additional cohorts will be completed in 2026.About Rona TherapeuticsRona Therapeutics is
More news about: Rona Therapeutics
Dec 15, 2025, 08:00 ET Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
ApicHope.About GoutGout is the most common form of inflammatory arthritis. Gout is caused by high levels of uric acid in the body that accumulate around the joints and other tissues and can result in flares that cause intense pain. When gout is left untreated, it can become a progressive
More news about: Arthrosi Therapeutics
Dec 15, 2025, 08:00 ET Atossa Therapeutics Presents Four Clinical Trial Updates Highlighting (Z)-Endoxifen Research at the 2025 San Antonio Breast Cancer Symposium
the breast care continuum," said Steven Quay, M.D., Ph.D., Atossa Therapeutics' President and Chief Executive Officer. "With support from our growing body of clinical evidence, we continue to advance our high value clinical programs. Following our more streamlined pathway for our Phase 2 EVANGELINE study,
More news about: Atossa Therapeutics Inc
Dec 15, 2025, 07:00 ET Herbivore Debuts Exclusive Bodycare Collection and Partnership with Ulta Beauty
effective, plant-active formulas inspired by the power of nature. With this Body Collection, we're extending that philosophy beyond skincare, bringing plant-powered, thoughtful formulations to the ritual of caring for your whole body. Partnering with Ulta allows us to share that experience with a whole new
More news about: Herbivore
Dec 15, 2025, 06:59 ET Automotive Aramid Fiber Market worth $1.30 billion by 2030 - Exclusive Report by MarketsandMarkets™
fraction of the weight of traditional materials like steel and some aluminum alloys. These composites are increasingly used in structural parts such as body panels, underbody protection shields, reinforcement beams, and interior components, where weight reduction can significantly enhance overall vehicle
More news about: MarketsandMarkets
Dec 15, 2025, 06:30 ET Polyhydroxyalkanoate (PHA) Market worth $265.2 million by 2030 - Exclusive Report by MarketsandMarkets™
medical field. PHA is used in sutures, tissue-engineering scaffolds, drug-delivery systems, and wound care products as it can safely degrade within the body without leaving behind residual toxic products. Increasing research on more sophisticated biomaterials, coupled with a rising number of injectable medical
More news about: MarketsandMarkets
Dec 15, 2025, 05:39 ET BE OPEN celebrates the Designing Futures 2050 winners at the United Nations Environment Assembly in Nairobi
UNEA is the world's highest decision-making body on the environment, and it is critical for addressing the shared environmental threats. The Assembly brings together ministers, intergovernmental organizations,
More news about: BE OPEN Foundation
Dec 15, 2025, 05:31 ET BE OPEN celebrates the Designing Futures 2050 winners at the United Nations Environment Assembly in Nairobi
UNEA is the world's highest decision-making body on the environment, and it is critical for addressing the shared environmental threats. The Assembly brings together ministers, intergovernmental organizations,
More news about: BE OPEN Foundation
Dec 14, 2025, 17:00 ET PMET Announces Multiple New Lithium/Caesium Discoveries in 2025 Drilling at the Shaakichiuwaanaan Property
mineralized body. • The principal mineralized bodies are relatively undeformed and very competent, although have meaningful structural control. • At CV5, the principal mineralized body and adjacent
More news about: PMET Resources Inc.
Dec 13, 2025, 15:57 ET Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
here.About GoutGout is the most common form of inflammatory arthritis. Gout is caused by high levels of uric acid in the body that accumulate around the joints and other tissues and can result in flares that cause intense pain. When gout is left untreated, it can become a progressive
More news about: Swedish Orphan Biovitrum AB
Dec 13, 2025, 15:52 ET Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
here.About GoutGout is the most common form of inflammatory arthritis. Gout is caused by high levels of uric acid in the body that accumulate around the joints and other tissues and can result in flares that cause intense pain. When gout is left untreated, it can become a progressive
More news about: Swedish Orphan Biovitrum AB
Dec 12, 2025, 20:25 ET U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*
cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC), refers to prostate cancer that has spread to other parts of the body but still responds to hormone therapy (androgen deprivation therapy).3 While the treatment landscape has advanced in recent years, almost
More news about: Johnson & Johnson
Dec 12, 2025, 17:47 ET Pilates Addiction Celebrates 200 Territories with Immersive Art Basel-Inspired Pop-Up at the Fontainebleau Miami
the brand's patented WundaFormer, exclusive to Pilates Addiction, and is led by certified Educators who guide clients through anatomy-informed, full-body training designed to build strength, control, and mobility. The signature method fuses intensity with precision, creating sessions that challenge, transform,
More news about: Pilates Addiction
Dec 12, 2025, 16:29 ET Oklahoma Proton Center lauds results of groundbreaking clinical study
exposure and collateral damage to normal tissue. Traditional radiation therapy uses photons (or X-rays) rather than protons. Photons pass through the body without stopping, leaving both an entry and exit dose of radiation in non-targeted areas which can result in collateral damage to normal tissues.The
More news about: Oklahoma Proton Center
Dec 12, 2025, 12:00 ET Jeep® Brand Unveils Wrangler Whitecap, Second Exclusive Model in Yearlong Twelve 4 Twelve Celebration of 85 Years of Off-road Leadership
Wrangler Whitecap are now open, with a starting MSRP of $495 on Rubicon X, $2,690 on Sahara (includes optional body-color hardtop) and $3,185 on Rubicon (includes optional body-color hardtop and body-color fender flares)Jeep BrandFor nearly 85 years, Jeep has been a global leader in
More news about: Stellantis
Dec 12, 2025, 11:45 ET Updated data for Lilly's Inluriyo™ (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio® (abemaciclib) in ER+, HER2- advanced breast cancer
Metastatic/Advanced Breast CancerMetastatic/advanced breast cancer (ABC) is a cancer that has spread from the breast tissue to other parts of the body. Locally advanced breast cancer means the cancer has grown outside the organ where it started but has not yet spread to other parts of the body.1 Of
More news about: Eli Lilly and Company
Dec 12, 2025, 10:30 ET NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor
cell death. Unfortunately, current systemically administered cisplatin formulations are associated with numerous severe side effects throughout the body. In addition, cisplatin does not cross the blood brain barrier well, limiting its efficacy in brain tumors, making systemically administered cisplatin
More news about: NanOlogy, LLC
Dec 12, 2025, 10:15 ET Unmanned Underwater Vehicles Market worth $8.72 billion by 2030 - Exclusive Report by MarketsandMarkets™
Autonomous Underwater Vehicle Market by Shape (Torpedo, Laminar Flow Body, Streamlined Rectangular Style, Multi-Hull Vehicle), Type (Shallow, Medium, Large), System, Speed, Propulsion, Application, Cost and Region - Global
More news about: MarketsandMarkets
Dec 12, 2025, 09:05 ET The Little Nell Brings Skincare Luminary and Celebrity Esthetician, Georgia Louise, to Aspen for an Exclusive Winter Residency
lifestyle philosophy that celebrates the life-affirming pleasure of active pursuits, the restorative power of nature, and the integration of mind, body, and spirit. This mirrors Georgia's approach, which is based in science, innovation, and a deep understanding of holistic skincare, guiding clients toward
More news about: Aspen One
Dec 12, 2025, 08:45 ET Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast Cancer Models at SABCS 2025
tumor-growth inhibition (TGI) in HR+ (MCF7) and TNBC (MDA-MB-468) in vivo models, with all treatment regimens well tolerated and no significant changes in body weight observed.
More news about: Actinium Pharmaceuticals, Inc.
Dec 12, 2025, 08:42 ET SYNEVIT® Expands West Coast Presence With Placement in Harvest Natural Foods
help consumers, and can be dangerous when unsupervised), SYNEVIT's formulas focus on providing RDA (recommended daily allowance) servings that give the body precise doses of targeted nutritional support. Health and wellness technology is also an important factor. The brand uses things like blister packaging
More news about: Synevit
Dec 12, 2025, 08:35 ET Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy
easily damaged and cannot repair themselves, resulting in progressive muscle weakness and degeneration. The dystrophin gene, the largest in the human body, contains 79 exons. Current disease-modifying therapeutic approaches for DMD include antisense oligonucleotides (ASO) mediated exon skipping, gene therapy,
More news about: Ractigen Therapeutics
Dec 12, 2025, 08:34 ET Lone Star Botanicals' Mushroom Powders Support Health During the Holidays
move across towns, cities, and states in December.The best defense against getting sick in the weeks ahead is the body itself. Natural dietary supplements support the body as its inherent immune system works to guard against viruses and bacteria. Supplements can also help with digestive health
More news about: Lone Star Botanicals